New York, March 31, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Contract Development Manufacturing Organizations Global Market Report 2023" - https://www.reportlinker.com/p06241902/?utm_source=GNW
, Aenova Holding, Almac Group, Vetter, and Covance Inc.,
The global contract development manufacturing organizations market grew from $196.26 billion in 2022 to $218.64 billion in 2023 at a compound annual growth rate (CAGR) of 11.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The contract development manufacturing organizations market is expected to grow to $339.72 billion in 2027 at a CAGR of 11.6%.
The contract development manufacturing organizations market includes revenues earned by entities by formulation, analytical services, blending, coating, and converting.The market value includes the value of related goods sold by the service provider or included within the service offering.
Only goods and services traded between entities or sold to end consumers are included.
Contract development manufacturing organizations refer to businesses that work on a contract basis with the pharmaceutical sector to provide medication development and manufacturing services. These businesses enable the pharmaceutical industry to outsource some of its operations, freeing up crucial time to concentrate on medication development and marketing.
North America was the largest region in contract development manufacturing organizations market in 2022. The regions covered in the contract development manufacturing organizations market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The contract development manufacturing organizations are segmented by service into CMO, CRO; by product into small molecules, biologics and by end user into big pharma, small and mid-size pharma, generic pharmaceutical companies, and other end users.
The growing demand for pharmaceutical products due to the increase in chronic diseases and the geriatric population contributed to the growth of the contract development manufacturing organizations market.Rising chronic diseases and geriatric population has enabled pharmaceutical companies to manufacture biologics and biosimilars quickly, and most pharmaceutical firms have contracted contract production and manufacturing organizations operating on a contractual basis to handle and coordinate the company’s tasks, operations and tests.
For instance, according to the World Health Organization, the prevalence of chronic diseases rose by 57% in 2020 and by 2050 the world’s population of 60 years and older is projected to rise to 2 billion. Therefore, the growing demand for pharmaceutical products is projected to drive the growth of the contract development manufacturing organizations market.
Stringent government regulations in the drug approval process may restrict the growth of the contract development manufacturing organizations market.Several governments across the globe are enforcing controls on pharmaceutical firms to safeguard the population from adverse drug effects.
These regulations further delay the process of introducing innovative pharmaceuticals onto the marketplace.For instance, on average, it requires at least ten years for a new drug to finish the process from the early creation to the marketplace, with clinical studies itself lasting six to seven years on average.
According to data from PhRMA in 2020, the average chance of clinical success (the possibility that a drug undergoing clinical trials will finally be accepted) is calculated to be less than 12%. Therefore, the stringent government regulations are projected to impede the growth of the contract development manufacturing organizations market over the coming years.
The introduction of custom solutions is a key trend gaining popularity in the market for contract development and manufacturing organizations.Contract development and manufacturing companies focus on the implementation of custom technologies to address the unique needs of individual research applications.
For instance, in October 2022, Aenova Holding GmbH, a Germany based pharmaceutical and healthcare contract manufacturing company, entered into a strategic partnership with Microcaps, a Switzerland based pharmaceutical company.Through this collaboration, both companies can develop and produce medicines, food supplements, and many other things more quickly and better.
Microcaps will share their knowledge of cutting-edge, highly accurate microencapsulation and Utilizing a patented technological platform, the technique allows for customized formulations, such as in release, protective coating, and texture.
In February 2022, Recipharm AB, a Sweden based pharmaceutical contract development and manufacturing company, acquired Arranta Bio for an undisclosed amount.Through this acquisition, Recipharm forms the basis of a plan to offer contract development and manufacturing services that are scientifically unique to innovative drug developers in the biologics industry, increases its capabilities in new biologics modalities, and will deliver a high level of diversification across many technologies and modalities.
Arranta Bio is a US-based contract development and manufacturing organization (CDMO) that collaborates with businesses looking to develop and produce novel medicines and complicated biological pharmaceuticals.
The countries covered in the contract development manufacturing organizations market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
The contract development manufacturing organizations market research report is one of a series of new reports that provides contract development manufacturing organizations market statistics, including contract development manufacturing organizations industry global market size, regional shares, competitors with a contract development manufacturing organizations market share, detailed contract development manufacturing organizations market segments, market trends and opportunities, and any further data you may need to thrive in the contract development manufacturing organizations industry. This contract development manufacturing organizations market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Read the full report: https://www.reportlinker.com/p06241902/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
